๐Ÿ›๏ธ Verified NIH Record โ€ข Updated 2026-03-11

Strength and Muscle Related Outcomes for Nutrition and Lung Function in CF (NCT05639556)

๐Ÿ”ต Active, Not Recruiting Interventional Protocol ๐Ÿ“Š Observational Clinical Research Sponsor: Jaeb Center for Health Research

๐Ÿฉบ Plain-English Summary (8th-Grade Level)

The goal of the study is to examine multiple markers of anthropometrics, body composition, sarcopenia and frailty and compare them to dual energy X-ray absorptiometry (DXA) output, which is considered the current clinical gold-standard tool to measure body composition. The result of this study will provide detailed data regarding the nutrition and body composition within this Cystic Fibrosis population and also provide a baseline evaluation for use of these biomarkers in the future studies including evaluation of nutritional intervention. Further, the study will also include psychosocial and other patient-reported outcomes and medical contributors to understand their contributions to the nutritional failure in the adult advanced lung disease population. Finally, the study will evaluate both established and emerging nutritional and body composition parameters and link them to clinical outcomes in adults with CF across the spectrum of pulmonary function.

Who can join: Review the eligibility criteria below.

Location: University of Arizona โ€” Tucson, Arizona

Age range: 18 Years

๐Ÿงช Interventions in This Study

๐Ÿ“‹ "Do I Qualify?" โ€” 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria โ†—

๐Ÿ“ All Participating Trial Locations (23 Sites)

  • University of Arizona โ€” Tucson, Arizona
  • University of Arkansas for Medical Sciences (UAMS) โ€” Little Rock, Arkansas
  • Emory โ€” Atlanta, Georgia
  • Northwestern University โ€” Chicago, Illinois
  • University of Iowa โ€” Iowa City, Iowa
  • University of Kentucky โ€” Lexington, Kentucky
  • Tulane University โ€” New Orleans, Louisiana
  • John Hopkins University โ€” Baltimore, Maryland
  • Massachusetts General Hospital (MGH) โ€” Boston, Massachusetts
  • Boston Children's Hospital and Brigham and Women's CF Center โ€” Boston, Massachusetts
  • University of Minnesota โ€” Minneapolis, Minnesota
  • Washington University School of Medicine (St. Louis) โ€” St Louis, Missouri
  • Rutgers Health โ€” New Brunswick, New Jersey
  • New York Medical College (NYMC) โ€” Hawthorne, New York
  • Northwell LIJ Adult Cystic Fibrosis Center โ€” New Hyde Park, New York
  • University of Cincinnati โ€” Cincinnati, Ohio
  • University Hospitals โ€” Cleveland, Ohio
  • University of Oklahoma Sciences Center โ€” Oklahoma City, Oklahoma
  • Oregon Health and Science University โ€” Portland, Oregon
  • University of Pittsburgh Medical Center โ€” Pittsburgh, Pennsylvania
  • Medical University of South Carolina โ€” Charleston, South Carolina
  • Baylor University โ€” Houston, Texas
  • University of Virginia Cystic Fibrosis Center โ€” Charlottesville, Virginia

๐Ÿ’ฐ Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

Explore by condition: All Cystic Fibrosis clinical trials

๐Ÿ’ก How to Participate

  1. Check the checklist above to see if you may qualify.
  2. Review the official NIH record below to find the coordinating site.
  3. Ask about the visit schedule, what is covered at no cost, and any travel support.
  4. Confirm with your own doctor before making a decision.
๐Ÿ›๏ธ View Official NIH Record โ†—